Multicenter evaluation of the new Etest gradient diffusion method for piperacillin-tazobactam susceptibility testing of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex

Authors

Sergio García-Fernández, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS)
Yohann Bala, bioMérieux Global Clinical Affairs, Marcy l’Etoile
Tom Armstrong, bioMérieux Global Clinical Affairs, Hazelwood
María García-Castillo, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS)
Carey-Ann D. Burnham, Washington University School of Medicine in St. Louis
Meghan A Wallace, Washington University School of Medicine in St. Louis
Dwight Hardy, University of Rochester
Gilles Zambardi, bioMérieux, La Balme les Grottes
Rafael Cantón, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS)

Journal

Journal of clinical microbiology

Publication Date

1-28-2020

Volume

58

Issue

2

First Page

e01042-19

Document Type

Open Access Publication

DOI

10.1128/JCM.01042-19

Rights and Permissions

García-Fernández S, Bala Y, Armstrong T, García-Castillo M, Burnham C-AD, Wallace MA, Hardy D, Zambardi G, Cantón R. 2020. Multicenter evaluation of the new Etest gradient diffusion method for piperacillin-tazobactam susceptibility testing of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex. J Clin Microbiol 58:e01042-19. https://doi.org/10.1128/JCM.01042-19.

Recommended Citation

García-Fernández, Sergio; Bala, Yohann; Armstrong, Tom; García-Castillo, María; Burnham, Carey-Ann D.; Wallace, Meghan A; Hardy, Dwight; Zambardi, Gilles; and Cantón, Rafael, "Multicenter evaluation of the new Etest gradient diffusion method for piperacillin-tazobactam susceptibility testing of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex." Journal of clinical microbiology. 58, 2. e01042-19 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/8877